Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01580982 · ClinicalTrials.gov registry record
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
A clinical trial of Lung Neoplasms, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01580982: Recruiting study of Lung Neoplasms, sponsored by University of Colorado, Denver.
NCT01580982 is a study of Lung Neoplasms that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 500 participants, above the 444-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01580982, a study of Lung Neoplasms, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Cancer Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-01-23 |
| Est. Completion | 2029-01-30 |
What NCT01580982 shows while recruiting
NCT01580982 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01580982 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01580982 about?
NCT01580982 is a clinical study titled "Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer". The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
What is the current status of trial NCT01580982?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2012-01-23. Estimated completion is 2029-01-30.
What conditions does trial NCT01580982 study?
This clinical trial studies the following conditions: Lung Neoplasms.
Who is sponsoring clinical trial NCT01580982?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01580982 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01580982's enrollment target sits among peer trials
500 7th of 22 higher than 16 of 22 other Lung Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Specimen Banking From Patients With Lung Cancer
RECRUITING
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RECRUITING · NA
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI